Safety and Efficacy of Gatifloxacin Therapy for Children with Recurrent Acute Otitis Media (AOM) and/or AOM Treatment Failure | Zendy

Michael E. Pichichero | Zendy; Adriano Arguedas | Zendy; Ron Dagan | Zendy; Laura Lindenfeld | Zendy; Xavier SáezLlorens | Zendy; Kamal Hamed | Zendy; Roger Echols | Zendy

Open Access

Safety and Efficacy of Gatifloxacin Therapy for Children with Recurrent Acute Otitis Media (AOM) and/or AOM Treatment Failure

Author(s) -

Michael E. Pichichero,

Adriano Arguedas,

Ron Dagan,

Laura Lindenfeld,

Xavier SáezLlorens,

Kamal Hamed,

Roger Echols

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/431584

Subject(s) - medicine , gatifloxacin , acute otitis media , otitis , intensive care medicine , surgery , antibiotics , ciprofloxacin , biology , microbiology and biotechnology

Because of concerns about arthrotoxicity, fluoroquinolones are restricted for use in children. This study describes the safety and efficacy of gatifloxacin when used for treatment of children with recurrent acute otitis media (ROM) or acute otitis media (AOM) treatment failure (AOMTF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research